Endogenous Biological Targets

Endogenous Biological Targets is a general term encompassing all naturally occurring molecules within an organism that can serve as the site of action for therapeutic agents. These targets are typically proteins such as receptors, enzymes, ion channels, and transporters, which are involved in essential physiological processes like signal transduction and metabolism (Source: StatPearls, Drug Receptors and Pharmacodynamics). While specific targets within this category are the focus of drug discovery efforts to treat conditions like cancer or cardiovascular disease, the term itself is a broad classification. It represents the entire landscape of potential points of intervention for modulating biological pathways. Consequently, it is not a single specific molecule but a collective noun used in pharmacology and biotechnology to describe the entities that drugs interact with to produce a clinical effect (Source: IUPHAR/BPS Guide to Pharmacology). The identification of these targets is the cornerstone of modern drug development, allowing for the creation of targeted therapies with improved efficacy and reduced off-target effects. However, because the term is non-specific, it cannot be associated with a single mechanism of action or safety profile.

Other names

Biological targetsDrug targetsEndogenous targetsTherapeutic targets

Not applicable as this is a general category of targets rather than a specific molecular entity.